Claire Gaunt

Antibacterial Prophylaxis after Chemotherapy for Solid Tumors and Lymphomas

Michael Cullen, Neil Steven, Lucinda Billingham et al. · New England Journal of Medicine · 2005 · 423 citations · Full text

Medicine, Oncology, Pharmacology +17

Addressing overtreatment of screen detected DCIS; the LORIS trial

Adele Francis, Jeremy Thomas, Lesley Fallowfield et al. · European Journal of Cancer · 2015 · 375 citations · Full text

Medicine, Internal Medicine, Preventive Medicine +5

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Jennifer Pascoe, Aimee Jackson, Charlotte Gaskell et al. · BMC Cancer · 2021 · 98 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)

Jennifer Pascoe, Aimee E. Houlton, Charlotte Gaskell et al. · Research Square · 2021 · 78 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

David Cameron, James P. Morden, Peter Canney et al. · The Lancet Oncology · 2017 · 74 citations · Full text

Medicine, Oncology, Pharmacology +15